Open tender · Germany · Contract notice
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Mebeverin (ATC A03AA04).
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Mebeverin (ATC A03AA04)”. Bids close on 25 February 2027. To qualify, bidders need at least one similar completed work and Pharmazeutischer Unternehmer status.
The work
Conclusion of a non-exclusive discount contract for the drug Mebeverin (ATC A03AA04) from 01.05.2025 to 30.04.2027.
- Contract must be for Mebeverin (ATC A03AA04).
- Contract must be non-exclusive.
- Contract must be concluded within the open-house model.
Key facts
- Contract period
- 24 months
- Evaluation
- This is a contract conclusion process, not a public procurement tender.
What it takes to qualify
Worth a closer look
- The tender document states it is not a public procurement in the sense of Directive 2014/24/EU, which may imply a different submission process.
- The exact submission mode (online/offline) is not specified.
Experience
- At least 1 similar work — Prior experience with pharmaceutical discount contracts is implied by the requirement to be a 'pharmazeutischer Unternehmer'.
- Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) under § 4 Abs. 18 AMG.
Certifications and registrations
Pharmazeutischer Unternehmer statusMust be a pharmaceutical entrepreneur as defined by § 4 Abs. 18 AMG.
GST registration (optional)Not stated in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contract documentsApplicants must request and submit the contract documents.